| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2024―Dez―20 |
Association of Polypharmacy and Burden of Comorbidities on COVID-19 Adverse Outcomes in People with Type 1 or Type 2 Diabetes |
Juhi K. Gupta, Rathi Ravindrarajah, George Tilston, William Ollier, Darren M. Ashcroft, Adrian H. Heald |
| 2 |
[GO] |
2024―Apr―20 |
Effects of Two COVID-19 Lockdowns on HbA1c Levels in Patients with Type 1 Diabetes and Associations with Digital Treatment, Health Literacy, and Diabetes Self-Management: A Multicenter, Observational Cohort Study Over 3 Years |
Daniel Tajdar, Dagmar Lühmann, Laura Walther, Lasse Bittner, Martin Scherer, Ingmar Schäfer |
| 3 |
[GO] |
2024―Mrz―27 |
Association of Premorbid GLP-1RA and SGLT-2i Prescription Alone and in Combination with COVID-19 Severity |
Klara R. Klein, Trine J. Abrahamsen, Anna R. Kahkoska, G. Caleb Alexander, Christopher G. Chute, Melissa Haendel, Stephanie S. Hong, Hemalkumar Mehta, Richard Moffitt, Til Stürmer, Kajsa Kvist, John B. Buse |
| 4 |
[GO] |
2023―Nov―17 |
Telehealth Use and Healthcare Utilization Among Individuals with Type 2 Diabetes During the COVID-19 Pandemic: Evidence From Louisiana Medicaid Claims |
Yixue Shao, Lizheng Shi, Elizabeth Nauman, Eboni Price-Haywood, Charles Stoecker |
| 5 |
[GO] |
2023―Nov―15 |
Correction to: New-Onset Diabetes Mellitus in COVID-19: A Scoping Review |
Anca Pantea Stoian, Ioana-Cristina Bica, Teodor Salmen, Wael Al Mahmeed, Khalid Al-Rasadi, Kamila Al-Alawi, Maciej Banach, Yajnavalka Banerjee, Antonio Ceriello, Mustafa Cesur, Francesco Cosentino, Alberto Firenze, Massimo Galia, Su-Yen Goh, Andrej Janez, Sanjay Kalra, Nitin Kapoor, Peter Kempler, Nader Lessan, Paulo Lotufo, Dimitri P. Mikhailidis, Luigi Nibali, Nikolaos Papanas, Tiffany Powell-Wiley, Ali A. Rizvi, Amirhossein Sahebkar, Raul D. Santos, Peter P. Toth, Vijay Viswanathan, Manfredi Rizzo |
| 6 |
[GO] |
2023―Okt―06 |
Protective Effects of Home T2DM Treatment with Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Co-transporter-2 Inhibitors Against Intensive Care Unit Admission and Mortality in the Acute Phase of the COVID-19 Pandemic: A Retrospective Observational Study in Italy |
Vincenzo M. Monda, Claudio Voci, Felice Strollo, Angelina Passaro, Salvatore Greco, Marcello Monesi, Renato Bigoni, Francesca Porcellati, Daniela Piani, Ersilia Satta, Sandro Gentile |
| 7 |
[GO] |
2023―Okt―05 |
Correction to: Sars-Cov-2 Infection in People with Type 1 Diabetes and Hospital Admission: An Analysis of Risk Factors for England |
Adrian H. Heald, David A. Jenkins, Richard Williams, Rajshekhar N. Mudaliar, Amber Khan, Akheel Syed, Naveed Sattar, Kamlesh Khunti, Asma Naseem, Kelly A. Bowden-Davies, J. Martin Gibson, William Ollier |
| 8 |
[GO] |
2023―Sep―26 |
New-Onset Diabetes Mellitus in COVID-19: A Scoping Review |
Anca Pantea Stoian, Ioana-Cristina Bica, Teodor Salmen, Wael Al Mahmeed, Khalid Al-Rasadi, Kamila Al-Alawi, Maciej Banach, Yajnavalka Banerjee, Antonio Ceriello, Mustafa Cesur, Francesco Cosentino, Alberto Firenze, Massimo Galia, Su-Yen Goh, Andrej Janez, Sanjay Kalra, Nitin Kapoor, Peter Kempler, Nader Lessan, Paulo Lotufo, Dimitri P. Mikhaildiis, Luigi Nibali, Nikolaos Papanas, Tiffany Powell-Wiley, Ali A. Rizvi, Amirhossein Sahebkar, Raul D. Santos, Peter P. Toth, Vijay Viswanathan, Manfredi Rizzo |
| 9 |
[GO] |
2023―Aug―25 |
Sars-Cov-2 Infection in People with Type 1 Diabetes and Hospital Admission: An Analysis of Risk Factors for England |
Adrian H. Heald, David A. Jenkins, Richard Williams, Rajshekhar N. Mudaliar, Amber Khan, Akheel Syed, Naveed Sattar, Kamlesh Khunti, Asma Naseem, Kelly A. Bowden-Davies, J. Martin Gibson, William Ollier |
| 10 |
[GO] |
2023―Feb―22 |
The Effect of the COVID-19 Pandemic on HbA1c Testing: Prioritization of High-Risk Cases and Impact of Social Deprivation |
David Holland, Adrian H. Heald, Fahmy F. W. Hanna, Mike Stedman, Pensée Wu, Julius Sim, Christopher J. Duff, Helen Duce, Lewis Green, Jonathan Scargill, Jonathon D. Howe, Sarah Robinson, Ian Halsall, Neil Gaskell, Andrew Davison, Mark Simms, Angela Denny, Martin Langan, Anthony A. Fryer |
| 11 |
[GO] |
2022―Dez―27 |
Absolute Hyperglycemia versus Stress Hyperglycemia Ratio for the Prognosis of Hospitalized Patients with COVID-19 in the First Months of the Pandemic: A Retrospective Study |
Alexandra A. Matias, Inês Manique, Teresa Sabino, Teresa Rego, Claudia Mihon, António Panarra, Manfredi Rizzo, José Silva-Nunes |
| 12 |
[GO] |
2022―Dez―07 |
COVID-19 Vaccination and Diabetes Mellitus: How Much Has It Made a Difference to Outcomes Following Confirmed COVID-19 Infection? |
Adrian H. Heald, David A. Jenkins, Richard Williams, Rajshekhar N. Mudaliar, Asma Naseem, Kelly A. Bowden Davies, J. Martin Gibson, Yonghong Peng, William Ollier |
| 13 |
[GO] |
2022―Nov―29 |
Sustained Improvement in Glycemic Control in Emerging Adults with Type 1 Diabetes 2 Years After the Start of the COVID-19 Pandemic |
Harshpreet Swaich, Andrew Advani |
| 14 |
[GO] |
2022―Nov―27 |
Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Hypertensive and/or Diabetic People Aged over 60 Years: A Prospective Open-Label Study |
Rongdong Huang, Xiaoqin Liu, Fangqin Xie, Junrong Li, Zhangbin Tang, Yuying Wu, Peicong Zhou, Dongjuan Zhang |
| 15 |
[GO] |
2022―Sep―22 |
Diabetes Mellitus May Exacerbate Liver Injury in Patients with COVID-19: A Single-Center, Observational, Retrospective Study |
Mutsuko Minata, Kouji H. Harada, Tomoyuki Yamaguchi, Tomoko Fujitani, Hidemitsu Nakagawa |
| 16 |
[GO] |
2022―Aug―27 |
The Dual Pandemics of COVID-19 and Obesity: Bidirectional Impact |
Nitin Kapoor, Sanjay Kalra, Wael Al Mahmeed, Khalid Al-Rasadi, Kamila Al-Alawi, Maciej Banach, Yajnavalka Banerjee, Antonio Ceriello, Mustafa Cesur, Francesco Cosentino, Alberto Firenze, Massimo Galia, Su-Yen Goh, Andrej Janez, Peter Kempler, Nader Lessan, Paulo Lotufo, Nikolaos Papanas, Ali A. Rizvi, Amirhossein Sahebkar, Raul D. Santos, Anca Pantea Stoian, Peter P. Toth, Vijay Viswanathan, Manfredi Rizzo |
| 17 |
[GO] |
2022―Apr―13 |
Mortality in People with Type 2 Diabetes Following SARS-CoV-2 Infection: A Population Level Analysis of Potential Risk Factors |
Adrian H. Heald, David A. Jenkins, Richard Williams, Matthew Sperrin, Rajshekhar N. Mudaliar, Akheel Syed, Asma Naseem, Kelly A. Bowden Davies, Yonghong Peng, Niels Peek, William Ollier, Simon G. Anderson, Gayathri Delanerolle, J. Martin Gibson |
| 18 |
[GO] |
2022―Mrz―25 |
The Risk Factors Potentially Influencing Hospital Admission in People with Diabetes, Following SARS-CoV-2 Infection: A Population-Level Analysis |
Adrian H. Heald, David A. Jenkins, Richard Williams, Matthew Sperrin, Helene Fachim, Rajshekhar N. Mudaliar, Akheel Syed, Asma Naseem, J. Martin Gibson, Kelly A. Bowden Davies, Niels Peek, Simon G. Anderson, Yonghong Peng, William Ollier |
| 19 |
[GO] |
2022―Jan―30 |
Retrospective Study on the Effects of Glucose Abnormality on COVID-19 Outcomes in Japan |
Yuya Nishida, Tomoya Mita, Makoto Hiki, Yasushi Matsushita, Toshio Naito, Hirotaka Watada |
| 20 |
[GO] |
2021―Okt―26 |
Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review |
Djordje S. Popovic, Nikolaos Papanas, Anca Pantea Stoian, Ali A. Rizvi, Andrej Janez, Manfredi Rizzo |
| 21 |
[GO] |
2021―Okt―06 |
Impact of SARS-CoV-2 on Progression of Glycemic and Cardiometabolic Variables and Changes in Insulin Indices: A Longitudinal Study |
Alpesh Goyal, Yashdeep Gupta, Mani Kalaivani, Neerja Bhatla, Nikhil Tandon |
| 22 |
[GO] |
2021―Sep―24 |
Correction to: Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study |
Rifat Emral, Cem Haymana, Ibrahim Demirci, Ilker Tasci, Mustafa Sahin, Erman Cakal, Naim Ata, Ugur Unluturk, Tevfik Demir, Derun Ertugrul, Ibrahim Sahin, Aysegül Atmaca, Osman Celik, Murat Caglayan, Kazim Yalcin Arga, Selcuk Dagdelen, Serpil Salman, Ilhan Satman, Alper Sonmez |
| 23 |
[GO] |
2021―Aug―16 |
Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study |
Rifat Emral, Cem Haymana, Ibrahim Demirci, Ilker Tasci, Mustafa Sahin, Erman Cakal, Naim Ata, Ugur Unluturk, Tevfik Demir, Derun Ertugrul, Ibrahim Sahi, Aysegül Atmaca, Osman Celik, Murat Caglayan, Kazim Yalcin Arga, Selcuk Dagdelen, Serpil Salman, Ilhan Satman, Alper Sonmez |
| 24 |
[GO] |
2021―Aug―14 |
The Challenge of Sustainable Access to Telemonitoring Tools for People with Diabetes in Europe: Lessons from COVID-19 and Beyond |
Pratik Choudhary, Virginia Bellido, Matthijs Graner, Bernd Altpeter, Americo Cicchetti, Isabelle Durand-Zaleski, Finn Børlum Kristensen |
| 25 |
[GO] |
2021―Aug―02 |
Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID Future |
Thomas Danne, Catarina Limbert, Manel Puig Domingo, Stefano Del Prato, Eric Renard, Pratik Choudhary, Alexander Seibold |
| 26 |
[GO] |
2021―Jul―18 |
Risk Factors Associated with COVID-19 Hospitalization and Mortality: A Large Claims-Based Analysis Among People with Type 2 Diabetes Mellitus in the United States |
Kristina S. Boye, Elif Tokar Erdemir, Nathan Zimmerman, Abraham Reddy, Brian D. Benneyworth, Matan C. Dabora, Emily R. Hankosky, M. Angelyn Bethel, Callahan Clark, Cody J. Lensing, Scott Sailer, Ramira San Juan, Robert J. Heine, Lida Etemad |
| 27 |
[GO] |
2021―Jul―09 |
The Impact of COVID-19 Lockdown on Metabolic Control and Access to Healthcare in People with Diabetes: the CONFI-DIAB Cross-Sectional Study |
Lisa Ludwig, Nicolas Scheyer, Thomas Remen, Bruno Guerci |
| 28 |
[GO] |
2021―Mrz―17 |
Diabetic Ketoacidosis at Emergency Department Presentation During the First Months of the SARS-CoV-2 Pandemic in Israel: A Multicenter Cross-Sectional Study |
Ron Jacob, Giora Weiser, Danna Krupik, Dania Takagi, Shuny Peled, Naama Pines, Saar Hashavya, Hagar Gur-Soferman, Shirly Gamsu, Or Kaplan, Michal Maimon, Shahar Oren, Gabi Padeh, Itai Shavit |
| 29 |
[GO] |
2020―Dez―26 |
New-Onset Diabetes in COVID-19: Time to Frame Its Fearful Symmetry |
Stella Papachristou, Iliana Stamatiou, Anca P. Stoian, Nikolaos Papanas |
| 30 |
[GO] |
2020―Dez―12 |
Insulinization in T2DM with Basal Analogues During COVID-19 Pandemic: Expert Opinion from an Indian Panel |
Manoj Chawla, Sunil M. Jain, Jothydev Kesavadev, Brij M. Makkar, Vijay Viswanathan, Mangesh Tiwaskar, Aravind R. Sosale, Vijay Negalur, Kirtikumar D. Modi, Mukulesh Gupta, Surinder Kumar, Santosh Ramakrishnan, Nilakshi Deka, Nirmalya Roy |
| 31 |
[GO] |
2020―Dez―05 |
Inpatient Hyperglycemia Management and COVID-19 |
Virginia Bellido, Antonio Pérez |
| 32 |
[GO] |
2020―Okt―14 |
A Response To: Sodium-Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions |
Antonio C. Bossi, Franco Forloni, Paolo L. Colombelli |
| 33 |
[GO] |
2020―Okt―14 |
Sodium-Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions |
Dimitrios Patoulias, Christodoulos Papadopoulos, Alexandra Katsimardou, Maria Toumpourleka, Michael Doumas |
| 34 |
[GO] |
2020―Sep―03 |
COVID-19, Diabetes and Ramadan |
Tahseen A. Chowdhury, Salman Waqar, Sufyan Hussain, Syed H. Ahmed, Ateeq Syed, Ali Karamat, Ahmed Helmy, Nazim Ghouri |
| 35 |
[GO] |
2020―Aug―04 |
ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role? |
Vincenzo M. Monda, Francesca Porcellati, Felice Strollo, Sandro Gentile |
| 36 |
[GO] |
2020―Jul―18 |
Basal-Bolus Insulin Regimen for Hospitalised Patients with COVID-19 and Diabetes Mellitus: A Practical Approach |
Bhawna Attri, Alpesh Goyal, Yashdeep Gupta, Nikhil Tandon |
| 37 |
[GO] |
2020―Jul―13 |
Diabetes and Novel Coronavirus Infection: Implications for Treatment |
David M. Williams, Asif Nawaz, Marc Evans |
| 38 |
[GO] |
2020―Jun―06 |
COVID-19: Impact of and on Diabetes |
Jonathan Schofield, Lalantha Leelarathna, Hood Thabit |
| 39 |
[GO] |
2020―Mai―23 |
Lack of Efficacy of SGLT2-i in Severe Pneumonia Related to Novel Coronavirus (nCoV) Infection: No Little Help from Our Friends |
Antonio Carlo Bossi, Franco Forloni, Paolo Luigi Colombelli |
| 40 |
[GO] |
2020―Mai―11 |
Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy |
Benedetta Maria Bonora, Federico Boscari, Angelo Avogaro, Daniela Bruttomesso, Gian Paolo Fadini |
| 41 |
[GO] |
2020―Mai―07 |
COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher’s Stone? |
Theano Penlioglou, Stella Papachristou, Nikolaos Papanas |
| 42 |
[GO] |
2020―Apr―29 |
The Need for Diabetes Care Customization in the ICU at the Time of SARS-CoV-2 Outbreak |
Sandro Gentile, Felice Strollo, Antonio Ceriello |
|
